Scientists at the University of California, San Francisco (UCSF), have discovered how to target a class of molecular switches called GTPases that are involved in a myriad of diseases—from Parkinson’s ...

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, today announced the launch of its biomarker discovery service, ...

Conscience, a non-profit focused on accelerating drug discovery in areas of unmet medical need using open science and radical collaboration, is pleased to announce three recipients and projects have ...

In a move that could reshape drug discovery, researchers at Harvard Medical School have designed an artificial intelligence model capable of identifying treatments that reverse disease states in cells ...

In a move that could reshape drug discovery, researchers at Harvard Medical School (HMS) have designed an artificial intelligence (AI) model they say is capable of identifying treatments that reverse ...

This review highlights how β-lactamases and efflux pumps, combined with mobile genetic elements, drive the rapid spread of multidrug-resistant (MDR) and extremely drug-resistant (XDR) pathogens, ...